PBS Nova premiered “Augmented,” a documentary film that features Prof. Hugh Herr and his research team’s work in developing brain controlled robotic limbs and reimagining amputation procedures. “Herr is teaming up with an injured climber and a surgeon at a leading Boston hospital to test a new approach to surgical amputation that allows prosthetic limbs to move and feel like the real thing,” writes PBS Nova.
STAT reporters Katie Palmer and Casey Ross spotlight how Prof. Regina Barzilay has developed an AI tool called Mirai that can identify early signs of breast cancer from mammograms. “Mirai’s predictions were rolled into a screening tool called Tempo, which resulted in earlier detection compared to a standard annual screening,” writes Palmer and Ross.
WBUR reporter Pamela Reynolds spotlights a new exhibit of Sharona Franklin’s work, which will be on display at the MIT List Visual Arts Center this coming February. “Franklin presents a new installation combining the themes of chronic illness with bioethics, environmental harm and holistic approaches to healthcare,” writes Reynolds.
Prof. Regina Barzilay speaks with Good Morning America about her work developing a new AI tool that could “revolutionize early breast cancer detection” by identifying patients at high risk of developing the disease. “If this technology is used in a uniform way,” says Barzilay, “we can identify early who are high-risk patients and intervene.”
Washington Post reporter Steve Zeitchik spotlights Prof. Regina Barzilay and graduate student Adam Yala’s work developing a new AI system, called Mirai, that could transform how breast cancer is diagnosed, “an innovation that could seriously disrupt how we think about the disease.” Zeitchik writes: “Mirai could transform how mammograms are used, open up a whole new world of testing and prevention, allow patients to avoid aggressive treatments and even save the lives of countless people who get breast cancer.”
NPR’s Ted Radio Hour spotlights the work of Alicia Chong Rodriguez SM ’17, SM ’18, who is trying to address the gaps that exist in women’s health data through a smart bra that can be used to acquire physiological data. Chong’s startup BloomerTech has “built medical-grade textile sensors that can adapt to multiple bra styles and sizes for continuous, reliable and repeatable data all around her torso and her heart.”
STAT reporter Katie Palmer writes that MIT researchers have developed a new machine learning model that can "flag treatments for sepsis patients that are likely to lead to a ‘medical dead-end,/ the point after which a patient will die no matter what care is provided.”
Joseph Coughlin, director of the MIT AgeLab, and Luke Yoquinto, a research associate at the AgeLab, emphasize the importance of increased investment in aging-related research in an article for The Boston Globe. Coughlin and Yoquinto call for “ramping up age-related disease research across the board: not just in health care and robotics, but also in smart-home tech, user design, transportation, workplace technologies, education and training, and nutrition. R&D in these fields won’t just improve lives; it will also strengthen tomorrow’s economy.”
Writing for STAT, lecturer Juhan Sonin and his colleagues underscore the importance of individuals owning the rights to their own health data. “Data ownership gives each of us the keys to our health puzzle and insight into how our data is used outside medical appointments to further research, innovation, and better health care for all,” writes Sonin and his co-authors. “It gives us the keys we need to care for ourselves and our loved ones, and to build health in our communities and our country at large.”
WCVB reporter Maria Stephanos shares the experience of Heather Walker, vice president of public relations for the Boston Celtics, who is enrolled in an MIT glioblastoma research study. Walker’s family and friends have created the Heather Walker Fund for Glioblastoma Research at Dana Farber, where “all the money raised will go to supporting a glioblastoma research study at MIT [that is] using immunotherapy and personalized vaccines,” says Stephanos.
Axios reporter Marisa Fernandez writes that researchers from MIT and Wilson Labs will be analyzing data from seven organ procurement organizations as part of an effort to better understand the American organ procurement system. "Working with this data is a first step towards making better decisions about how to save more lives through organ procurement and transplantation,” says Prof. Marzyeh Ghassemi. “We have an opportunity to use machine learning to understand potential issues and lead improvements in transparency and equity.”
Alicia Chong Rodriguez SM ’17, SM ’18 speaks with Boston Globe reporter Pranshu Verma about the inspiration for her startup BloomerTech, which is focused on addressing heart disease in women, and the underrepresentation of women in clinical trials. As part of this effort, BloomerTech is developing a “sensor-enabled bra that feeds real-time heart data to doctors running clinical trials on women’s cardiovascular disease.”
Writing for The Boston Globe, Visiting Prof. Susan J. Blumenthal and research scientist David Kong underscore the need to reimagine America’s public health infrastructure. “A new multidisciplinary academic field of public health technology should be established to integrate diverse expertise in public health, technology, engineering, data analytics, and design to help build the products, programs, and systems necessary to modernize the nation’s public health infrastructure and ready it for 21st-century challenges and opportunities,” they write.
Wall Street Journal reporter Sara Castellanos spotlights Prof. Markus Buehler’s work combining virtual reality with sound waves to help detect subtle changes in molecular motions. Castellanos notes that Buehler and his team recently found, “coronaviruses can be more lethal or infectious depending on the vibrations within the spike proteins that are found on the surface of the virus.”
Writing for The New York Times, Prof. Amy Finkelstein explores the need to reign in prices of drugs administered by physicians. “Economists tend to favor letting the private sector set prices, but this requires a well-functioning market,” writes Finkelstein. “In trying to base its payments on what other customers pay, Medicare has distorted the market for physician-administered drugs beyond reason.”